GB201514652D0 - Synthetic BTV VP2 multiepitope peptide vaccine - Google Patents

Synthetic BTV VP2 multiepitope peptide vaccine

Info

Publication number
GB201514652D0
GB201514652D0 GBGB1514652.5A GB201514652A GB201514652D0 GB 201514652 D0 GB201514652 D0 GB 201514652D0 GB 201514652 A GB201514652 A GB 201514652A GB 201514652 D0 GB201514652 D0 GB 201514652D0
Authority
GB
United Kingdom
Prior art keywords
peptide vaccine
synthetic btv
multiepitope peptide
multiepitope
btv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1514652.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Cape Town
Original Assignee
University of Cape Town
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Cape Town filed Critical University of Cape Town
Priority to GBGB1514652.5A priority Critical patent/GB201514652D0/en
Publication of GB201514652D0 publication Critical patent/GB201514652D0/en
Priority to PCT/IB2016/054925 priority patent/WO2017029619A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/425—Zeins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB1514652.5A 2015-08-18 2015-08-18 Synthetic BTV VP2 multiepitope peptide vaccine Ceased GB201514652D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1514652.5A GB201514652D0 (en) 2015-08-18 2015-08-18 Synthetic BTV VP2 multiepitope peptide vaccine
PCT/IB2016/054925 WO2017029619A1 (en) 2015-08-18 2016-08-17 Synthetic btv vp2 multiepitope peptide vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1514652.5A GB201514652D0 (en) 2015-08-18 2015-08-18 Synthetic BTV VP2 multiepitope peptide vaccine

Publications (1)

Publication Number Publication Date
GB201514652D0 true GB201514652D0 (en) 2015-09-30

Family

ID=54258781

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1514652.5A Ceased GB201514652D0 (en) 2015-08-18 2015-08-18 Synthetic BTV VP2 multiepitope peptide vaccine

Country Status (2)

Country Link
GB (1) GB201514652D0 (en)
WO (1) WO2017029619A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110408633B (en) * 2019-07-10 2022-06-24 郑州大学 Prokaryotic expression preparation method of BTV1 VP2 protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0426160D0 (en) * 2004-11-29 2004-12-29 Era Plantech S L Production of proteins

Also Published As

Publication number Publication date
WO2017029619A1 (en) 2017-02-23

Similar Documents

Publication Publication Date Title
IL268920A (en) Peptide vaccines
GB201418562D0 (en) Peptides
HUE050893T2 (en) Protein
GB201415344D0 (en) Protein
IL287985A (en) Koc1-derived peptide and vaccine including same
IL248276A0 (en) Carbohydrate-binding protein
GB201520536D0 (en) Peptides
PL3099793T3 (en) Protein
GB201401877D0 (en) Peptides
HK1253316A1 (en) Peptides
IL250215A0 (en) Cdca1-derived peptide and vaccine containing same
GB201514652D0 (en) Synthetic BTV VP2 multiepitope peptide vaccine
IL250235A0 (en) Urlc10-derived peptide and vaccine containing same
ZA201801358B (en) Synthetic btv vp2 fusion protein
GB201520534D0 (en) Peptides
GB201520535D0 (en) Peptides
GB201519667D0 (en) Peptides
GB201518700D0 (en) Peptides
GB201513320D0 (en) Peptides
GB201420645D0 (en) Peptides
GB201415235D0 (en) Trans-locating peptide
GB201412731D0 (en) Peptides
TH1601000676A (en) Peptide
GB201410686D0 (en) Peptides
GB201409010D0 (en) Peptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)